Targeting EndoS to auto-antibodies

将 EndoS 靶向自身抗体

基本信息

  • 批准号:
    10195779
  • 负责人:
  • 金额:
    $ 19.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-02-18 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

Autoantibodies, which recognize autoantigens (i.e., self-antigens), serve as both hallmarks and diagnostic markers of autoimmune diseases. Although autoimmune disease mechanisms are complex and involve various humoral and cellular immune responses, some are exclusively dependent on the presence of autoantibodies. Upon binding to their cognate autoantigens, self-reactive antibodies induce effector mechanisms of immunity through complement activation and/or Fc receptor binding. The resulting autoantibody-mediated effector mechanisms lead to chronic inflammation and the eventual tissue damage symptomatic of autoimmune disease. The effector functions mediated by IgG antibodies, whether they recognize self or foreign antigens, are entirely dependent on the presence of an N-linked complex type glycan on Asn297 of the IgG Fc region, which enables the antibody to bind Fc γ receptors (FcγRs) and activate complement, endowing the antibody with immune signaling capabilities. Endoglycosidases (i.e., enzymes that remove glycans from glycoproteins) can remove the glycan molecule linked to Asn297 and render IgG antibodies immunologically inert. Of all the known endoglycosidases, Endoglycosidase S (EndoS) is unique in that it removes only the Asn297-linked glycan from IgG antibodies. Due to its IgG-specific properties, EndoS pretreatment of pathological autoantibodies and/or injection of purified EndoS in animal models of autoimmunity has been shown to protect against or alleviate the symptoms of many autoimmune diseases. Although EndoS is exquisitely specific to IgG antibodies, it has no capacity to discriminate between antibodies with different antigen specificities. Instead, EndoS deglycosylates all IgG antibodies, including those that keep cancer in check, as well as those that are specific to foreign antigens that provide defense from infections. Engineering EndoS such that it recognizes and deglycosylates only autoantibodies, as opposed to all IgG antibodies, is essential for making a truly specific autoimmunity drug. We hypothesize that we can translate EndoS from an autoimmune disease therapeutic of great potential to one of actual clinical utility by constructing fusion proteins of EndoS linked to autoantigens (EndoS-autoAg) that will drive the targeted deglycosylation and inactivation of pathological autoantibodies, while leaving the remainder of the immune system functionally intact. We will provide proof-of-principle for this concept by: (1) optimizing EndoS-autoAg fusion protein properties for specificity and activity in vitro; and (2) investigating EndoS-autoAg fusion protein efficacy and specificity in vivo using a mouse model of autoimmune epidermolysis bullosa acquisita (EBA).
自身抗体,其识别自身抗原(即,自身抗原),作为标志和诊断 自身免疫性疾病的标志物。虽然自身免疫性疾病的机制是复杂的,并涉及各种 体液和细胞免疫应答中,有些完全依赖于自身抗体的存在。 自身反应性抗体与其同源自身抗原结合后,诱导免疫效应机制 通过补体激活和/或Fc受体结合。产生的自身抗体介导的效应器 这些机制导致慢性炎症和自身免疫性疾病的最终组织损伤症状。 由IgG抗体介导的效应器功能,无论它们识别自身抗原还是外来抗原,都完全是 依赖于IgG Fc区的Asn 297上N-连接的复合型聚糖的存在,这使得 抗体结合Fc γ受体(FcγRs)并激活补体,赋予抗体免疫原性, 信号能力。内切糖苷酶(即,从糖蛋白中除去聚糖的酶)可以除去 聚糖分子与Asn 297连接,并使IgG抗体免疫惰性。已知所有 内切糖苷酶,内切糖苷酶S(EndoS)是独特的,因为它仅从酶中去除Asn 297连接的聚糖。 IgG抗体。由于其IgG特异性性质,病理性自身抗体和/或 在自身免疫的动物模型中注射纯化的EndoS已经显示出保护或减轻了自身免疫性疾病。 许多自身免疫性疾病的症状。虽然EndoS对IgG抗体具有特异性,但它没有 区分不同抗原特异性抗体的能力。相反,EndoS去糖基化 所有IgG抗体,包括那些控制癌症的抗体,以及那些对外来抗原特异的抗体 提供抵抗感染的能力。工程化EndoS,使其仅识别和去糖基化 与所有IgG抗体相反,自身抗体对于制备真正特异性的自身免疫药物至关重要。我们 假设我们可以将EndoS从一种具有巨大潜力的自身免疫性疾病治疗剂转化为 通过构建与自身抗原连接的EndoS融合蛋白(EndoS-autoAg), 驱动病理性自身抗体的靶向去糖基化和失活,同时留下剩余的 免疫系统功能完好我们将通过以下方式为这一概念提供原理证明:(1)优化 EndoS-autoAg融合蛋白的体外特异性和活性特性;(2)研究EndoS-autoAg 融合蛋白在获得性自身免疫性大疱性表皮病小鼠模型中的体内功效和特异性 (EBA)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIC JOHN SUNDBERG其他文献

ERIC JOHN SUNDBERG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIC JOHN SUNDBERG', 18)}}的其他基金

Gatekeeping glycan metabolism in the human gut microbiome
人类肠道微生物组中的聚糖代谢把关
  • 批准号:
    10737225
  • 财政年份:
    2023
  • 资助金额:
    $ 19.53万
  • 项目类别:
Engineering mono-fucosylated IgGs to fine-tune antibody-mediated effector functions
工程化单岩藻糖基化 IgG 来微调抗体介导的效应功能
  • 批准号:
    10647938
  • 财政年份:
    2023
  • 资助金额:
    $ 19.53万
  • 项目类别:
Engineering antibody effector functions by Glycan Remodeling Yeast Display
通过聚糖重塑酵母展示工程化抗体效应子功能
  • 批准号:
    10494252
  • 财政年份:
    2021
  • 资助金额:
    $ 19.53万
  • 项目类别:
Targeting EndoS to auto-antibodies
将 EndoS 靶向自身抗体
  • 批准号:
    10356157
  • 财政年份:
    2021
  • 资助金额:
    $ 19.53万
  • 项目类别:
Engineering antibody effector functions by Glycan Remodeling Yeast Display
通过聚糖重塑酵母展示工程化抗体效应子功能
  • 批准号:
    10373251
  • 财政年份:
    2021
  • 资助金额:
    $ 19.53万
  • 项目类别:
Rationalizing glycoengineering strategies for immunotherapeutic antibodies
免疫治疗抗体糖工程策略的合理化
  • 批准号:
    10377400
  • 财政年份:
    2020
  • 资助金额:
    $ 19.53万
  • 项目类别:
Structure & Function of Clostridium difficile Type IV Pili
结构
  • 批准号:
    10087197
  • 财政年份:
    2020
  • 资助金额:
    $ 19.53万
  • 项目类别:
Towards one-step enzymatic defucosylation of antibodies
抗体的一步酶促去岩藻糖基化
  • 批准号:
    10176408
  • 财政年份:
    2020
  • 资助金额:
    $ 19.53万
  • 项目类别:
Towards one-step enzymatic defucosylation of antibodies
抗体的一步酶促去岩藻糖基化
  • 批准号:
    10041315
  • 财政年份:
    2020
  • 资助金额:
    $ 19.53万
  • 项目类别:
Rationalizing glycoengineering strategies for immunotherapeutic antibodies
免疫治疗抗体糖工程策略的合理化
  • 批准号:
    10598482
  • 财政年份:
    2020
  • 资助金额:
    $ 19.53万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.53万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 19.53万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 19.53万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.53万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 19.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.53万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 19.53万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 19.53万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 19.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 19.53万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了